Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort

PURPOSE OF REVIEW: This review highlights the problem of neuropsychiatric adverse effects (AEs) associated with elexacaftor/tezacaftor/ivacaftor (ETI), current suboptimal mitigation approaches, a novel testable mechanistic hypothesis, and potential solutions requiring further research. RECENT FINDIN...

Descripción completa

Detalles Bibliográficos
Autores principales: VanElzakker, Michael B., Tillman, Emma M., Yonker, Lael M., Ratai, Eva-Maria, Georgiopoulos, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
CYSTIC FIBROSIS: Edited by Elliott Dasenbrook and Cynthia D. Brown
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552811/
https://www.ncbi.nlm.nih.gov/pubmed/37655981
http://dx.doi.org/10.1097/MCP.0000000000001014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552811/
https://www.ncbi.nlm.nih.gov/pubmed/37655981
http://dx.doi.org/10.1097/MCP.0000000000001014

Ejemplares similares